Generation and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid Antibodies
Heinz Hillen(Abbott (Germany)), Ulrich Ebert(Abbott (Germany)), Stefan Barghorn(Ludwigshafen University of Business and Society), James P. Sullivan(Australian National University), Claudia Perez‐Cruz(Instituto Politécnico Nacional), Anton Bespalov(Abbott (Germany)), Marcel van Gaalen(Abbott (Germany)), Andreas Striebinger(Abbott (Germany)), Marc W. Nolte(Abbott (Germany)), Fred Van Leuven(KU Leuven), Hans E. Schoemaker(Abbott (Germany)), Reinhold Müller(Abbott (Germany)), Boris Labkovsky(AbbVie (United States)), Ingrid Van der Auwera(University of Illinois Chicago), Volker Nimmrich(Abbott (Germany))
Cited by 113
Related Papers
Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells
|Science Translational Medicine|2013|1.1k
Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain
|Journal of Biological Chemistry|1999|668
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
|Journal of Clinical Investigation|2004|622
Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency
|Proceedings of the National Academy of Sciences|1999|523